Traws Pharma (TRAW) Misses Q2 EPS by 11c

Traws Pharma (NASDAQ: TRAW) reported Q2 EPS of ($0.11). Revenue for the quarter came in at $2.73 million.

For earnings history and earnings-related data on Traws Pharma (TRAW) click here.

You May Also Be Interested In

• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• Jefferies says used farm equipment pricing stays under pressure
• L3Harris CEO steps down amid conduct review, shares drop